Fig. 8

Inhibition of Gsk3β enhances MenSCs survival in vivo. a shGFP and shGsk3β MenSCs were labeled with DiI before injection. b, c One week later, MenSCs were analysis in the heart, lung, liver, spleen, and kidney among the PBS, shGFP, and shGsk3β groups. n = 4 biological replicates, one-way ANOVA followed by Tukey test, *p < 0.05, **p < 0.01, and ***p < 0.001, shGFP versus shGsk3β. Data are provided as means ± SEM. Scale bars, 100 μm